Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis.

Najafi A, Chaechi Nosrati MR, Ghasemi E, Navi Z, Yousefi A, Majidiani H, Ghaneialvar H, Sayehmiri K, Galvan-Ramirez ML, Fakhar M.

Microb Pathog. 2019 Sep 17;137:103752. doi: 10.1016/j.micpath.2019.103752. [Epub ahead of print] Review.

PMID:
31539586
2.

Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis.

Yang S, Zhao W, Wang H, Wang Y, Li J, Wu X.

Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:166-173. doi: 10.1016/j.ejogrb.2018.06.031. Epub 2018 Jun 19.

PMID:
29980111
3.

Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.

Marous M, Huang WY, Rabkin CS, Hayes RB, Alderete JF, Rosner B, Grubb RL 3rd, Winter AC, Sutcliffe S.

Cancer Causes Control. 2017 Aug;28(8):889-898. doi: 10.1007/s10552-017-0919-6. Epub 2017 Jul 1.

4.

Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis.

Masha SC, Cools P, Sanders EJ, Vaneechoutte M, Crucitti T.

Sex Transm Infect. 2019 Feb;95(1):36-42. doi: 10.1136/sextrans-2018-053713. Epub 2018 Oct 19.

5.

Trichomonas vaginalis infection and risk of advanced prostate cancer.

Shui IM, Kolb S, Hanson C, Sutcliffe S, Rider JR, Stanford JL.

Prostate. 2016 May;76(7):620-3. doi: 10.1002/pros.23153. Epub 2016 Jan 28.

6.

Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis.

Hezarjaribi HZ, Fakhar M, Shokri A, Teshnizi SH, Sadough A, Taghavi M.

Parasitol Res. 2015 Apr;114(4):1291-300. doi: 10.1007/s00436-015-4393-3. Epub 2015 Mar 4. Review.

PMID:
25732256
7.

Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysis.

Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W.

Onco Targets Ther. 2016 Sep 6;9:5451-9. doi: 10.2147/OTT.S107595. eCollection 2016. Review.

8.

[Therapeutic aspects of trichomoniasis].

Vukićević J, Jankicević J.

Srp Arh Celok Lek. 2003 Mar-Apr;131(3-4):156-61. Serbian.

9.

Review of Trichomonas vaginalis in Iran, Based on Epidemiological Situation.

Arbabi M, Delavari M, Fakhrieh-Kashan Z, Hooshyar H.

J Reprod Infertil. 2018 Apr-Jun;19(2):82-88. Review.

10.

Association between human papillomavirus and prostate cancer: A meta-analysis.

Yin B, Liu W, Yu P, Liu C, Chen Y, Duan X, Liao Z, Chen Y, Wang X, Pan X, Tao Z.

Oncol Lett. 2017 Aug;14(2):1855-1865. doi: 10.3892/ol.2017.6367. Epub 2017 Jun 9.

11.

Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies.

Jiang X, Zhang M, Bai XY, Li S, Wu H.

Onco Targets Ther. 2016 Jul 22;9:4491-503. doi: 10.2147/OTT.S104775. eCollection 2016.

12.

A Systematic Review and Meta-Analysis on the Association between Hypertension and Tinnitus.

Yang P, Ma W, Zheng Y, Yang H, Lin H.

Int J Hypertens. 2015;2015:583493. doi: 10.1155/2015/583493. Epub 2015 Dec 31. Review.

13.

Hypertension and risk of prostate cancer: a systematic review and meta-analysis.

Liang Z, Xie B, Li J, Wang X, Wang S, Meng S, Ji A, Zhu Y, Xu X, Zheng X, Xie L.

Sci Rep. 2016 Aug 11;6:31358. doi: 10.1038/srep31358. Review.

14.

Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis.

Wang F, Qin Z, Si S, Tang J, Xu L, Xu H, Li R, Han P, Yang H.

Oncotarget. 2017 Jul 5;8(34):57440-57450. doi: 10.18632/oncotarget.19023. eCollection 2017 Aug 22.

15.

The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis.

Ge Y, Shi Q, Yao W, Cheng Y, Ma G.

Prostate Cancer Prostatic Dis. 2019 Oct 7. doi: 10.1038/s41391-019-0177-7. [Epub ahead of print] Review.

PMID:
31591455
16.

Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.

Raval AD, Thakker D, Vyas A, Salkini M, Madhavan S, Sambamoorthi U.

Prostate Cancer Prostatic Dis. 2015 Jun;18(2):110-21. doi: 10.1038/pcan.2014.52. Epub 2015 Feb 10.

17.

Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: a systematic review and meta-analysis.

Cai Q, Wang Z, Zhang W, Guo X, Shang Z, Jiang N, Tian J, Niu Y.

Tumour Biol. 2014 Jan;35(1):247-56. doi: 10.1007/s13277-013-1030-6. Epub 2013 Jul 26. Review.

PMID:
23888321
18.

The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.

Li Y, Huang Q, Zhou Y, He M, Chen J, Gao Y, Wang X.

Front Pharmacol. 2019 Jan 24;9:1494. doi: 10.3389/fphar.2018.01494. eCollection 2018.

19.

Helicobacter pylori infection and pancreatic cancer risk: A meta-analysis.

Guo Y, Liu W, Wu J.

J Cancer Res Ther. 2016 Dec;12(Supplement):C229-C232. doi: 10.4103/0973-1482.200744.

20.

Supplemental Content

Support Center